[Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
作者信息
Lavitola P de L, Higa S S
出版信息
Rev Paul Med. 1986 May-Jun;104(3):136-40.
PMID:3563266
Abstract
摘要
相似文献
1
[Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].[血管扩张剂在心力衰竭治疗药物中的应用]
Rev Paul Med. 1986 May-Jun;104(3):136-40.
2
Current indications for vasodilator therapy for left ventricular failure.
Compr Ther. 1985 Mar;11(3):39-46.
3
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.血管扩张剂疗法对慢性充血性心力衰竭死亡率的影响。退伍军人管理局合作研究的结果。
N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404.
4
[Modern vasodilator medication in refractory cardiac insufficiency].
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1983 Mar-Apr;35(2):129-34.
5
Use of vasodilator drugs in congestive heart failure.血管扩张剂在充血性心力衰竭中的应用。
Med Lett Drugs Ther. 1978 Oct 6;20(20):89-91.
6
[Treatment of cardiac failure with vasodilators (author's transl)].血管扩张剂治疗心力衰竭（作者译）
Schweiz Rundsch Med Prax. 1978 May 30;67(22):219-29.
7
8
[Peripheral vasodilators in the treatment of heart failure].[外周血管扩张剂在心力衰竭治疗中的应用]
Pediatriia. 1982 Jan(1):67-70.
9
The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
Circulation. 1993 Jun;87(6 Suppl):VI1-4.
10
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.退伍军人管理局心力衰竭血管扩张剂治疗合作研究：随机分组前变量对肼屈嗪和硝酸异山梨酯治疗降低死亡率的影响。
Circulation. 1987 May;75(5 Pt 2):IV49-54.
Zotero 插件